You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東方生物(688298.SH)2021年度預盈47.2億-51.2億元 同比增長181.45%-205.31%
格隆匯 01-14 18:12

格隆匯1月14日丨東方生物(688298.SH)公佈,預計2021年年度實現歸屬於母公司所有者的淨利潤47.2億元至51.2億元,與上年同期(法定披露數據)相比,將增加30.43億元至34.43億元,同比增加181.45%至205.31%。

歸屬於母公司所有者的扣除非經常性損益的淨利潤47億元至51億元,與上年同期(法定披露數據)相比,將增加30.41億元至34.41億元,同比增加183.30%至207.41%。

2021繼續受全球新冠疫情影響,公司新型冠狀病毒抗原快速檢測試劑(含家庭自測)繼續投入到疫事業中,產品在歐洲市場銷售業績繼續大幅度增長,促使2021度經營業績幅度增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account